Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002273 · ClinicalTrials.gov registry record · NA
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS
A NA study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- NA
- Development phase
NCT00002273: Completed NA study, sponsored by Hoffmann-La Roche.
NCT00002273 is a NA study that has completed, run by Hoffmann-La Roche. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002273, a NA study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To attempt to demonstrate the efficacy of ganciclovir (DHPG) treatment of cytomegalovirus (CMV) colitis in AIDS patients by evaluating both clinical and virologic parameters. To determine acceptability and the safety profile of a 2-week course of intravenous (IV) DHPG therapy.
Interventions
- DRUG Ganciclovir
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002273 record still lists
NCT00002273 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Ganciclovir is the first listed.
NCT00002273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002273 about?
NCT00002273 is a clinical study titled "A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS". To attempt to demonstrate the efficacy of ganciclovir (DHPG) treatment of cytomegalovirus (CMV) colitis in AIDS patients by evaluating both clinical and virologic parameters. To determine acceptability and the safety profile of a 2-week course of intravenous (IV) DHPG therapy.
What is the current status of trial NCT00002273?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002273?
The interventions under investigation include: Ganciclovir (DRUG).
Who is sponsoring clinical trial NCT00002273?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.